Currently out of the existing stock ratings of Kevin Caliendo, 157 are a BUY (49.06%), 11 are a SELL (3.44%), 152 are a HOLD (47.5%).

Kevin Caliendo

Work Performance Price Targets & Ratings Chart

Analyst Kevin Caliendo, currently employed at UBS, carries an average stock price target met ratio of 64.15% that have a potential upside of 17.98% achieved within 252 days.

Kevin Caliendo’s has documented 626 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PINC, Premier at 24-Sep-2025.

Wall Street Analyst Kevin Caliendo

Analyst best performing recommendations are on AGTI (AGILITI).
The best stock recommendation documented was for CVS (CVS HEALTH CORP) at 2/10/2025. The price target of $59 was fulfilled within 2 days with a profit of $5.84 (10.99%) receiving and performance score of 54.93.

Average potential price target upside

of $68.85 (31.11%) on CI (CIGNA CORP).
of $55.63 (17.45%) on ALGN (ALIGN TECHNOLOGY).
of $51.7 (16.3%) on MCK (MCKESSON).

ABC AmerisourceBergen ALGN Align Technology CAH Cardinal Health CERN Cerner Corp CI Cigna Corp CVS CVS Health Corp DGX Quest Diagnostics HSIC Henry Schein LH Laboratory of America Holdings MCK McKesson OMI Owens & Minor SDC SmileDirectClub TDOC Teladoc TEVA Teva Pharma Industries Ltd ADR UNH UnitedHealth Group WBA Walgreens Boots Alliance ALHC Alignment Healthcare LLC JNJ Johnson & Johnson LFST Lifestance Health Group SGFY Signify Health DPLO Diplomat Pharmacy XRAY Dentsply Sirona ELV Elevance Health HUM Humana PINC Premier AGTI Agiliti AHCO Adapthealth Corp AMWL American Well Corp PDCO Patterson Companies MOH Molina Healthcare CNC Centene Corp EVH Evolent Health GDRX Goodrx Holdings COR Cencora NVST Envista Holdings Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Charles Rhyee (TD COWEN)